Clinical Trials Directory

Trials / Completed

CompletedNCT04738552

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning

Status
Completed
Phase
Study type
Observational
Enrollment
233 (actual)
Sponsor
Neuro Event Labs Inc. · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Increased computational power has made it possible to implement complex image recognition tasks and machine learning to be implemented in every day usage. The computer vision and machine learning based solution used in this project (Nelli) is an automatic seizure detection and reporting method that has a CE mark for this specific use. The present study will provide data to expand the utility and detection capability of NELLI and enhance the accuracy and clinical utility of automated computer vision and machine learning based seizure detection.

Detailed description

This is a prospective, blind comparison to the clinical gold standard for seizure characterization. This study is intended to compare the Nelli Software's ability to identify seizure events to vEEG review in adults with suspected nighttime seizures. Simultaneously, Nelli will continuously record audio and video while video-electroencephalography (vEEG) is recorded per typical standard of care. Events with positive motor manifestations will be independently identified, following standard clinical practice, by three epileptologists using clinical vEEG data. Nelli Software will review the audio and video data and independently identify events with positive motor manifestations. The outcomes of event identification will be compared between Epileptologists and the Nelli Software. For each category of event captured the positive percent agreement will be calculated using the exact binomial method. The primary endpoint of this study is to demonstrate that Nelli is able to identify seizures that have a positive motor component with a sensitivity of \> 70%.

Conditions

Interventions

TypeNameDescription
DEVICENelliNelli detects and registers activity that is indicative of seizure events. Nelli captures, stores, and processes video and audio recordings from each patient. Biomarker data is collected during periods of rest for the length of an examination period, which may span several days or months (when used inside and outside of a hospital setting, respectively), as prescribed by a treating physician.

Timeline

Start date
2020-01-09
Primary completion
2022-11-27
Completion
2022-11-27
First posted
2021-02-04
Last updated
2024-11-25

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04738552. Inclusion in this directory is not an endorsement.